Product
Questran
1 clinical trial
4 indications
Indication
Orphan Cholestatic Liver DiseasesIndication
Primary Biliary CirrhosisIndication
Alagille syndromeClinical trial
A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of A4250 as Monotherapy, and in Combination With Colonic Release Cholestyramine (A3384) or Commercially Available Cholestyramine (Questran™) in Healthy SubjectsStatus: Completed, Estimated PCD: 2014-05-01